This article provides examples of how AI is helping to shape drug discovery, from drug design through to clinical trials.

Researchers have applied AI to every step of the drug development process. But this might not be enough to design safe and ...

PostEra, a biotechnology company specializing in machine learning for preclinical drug discovery, today announced an ...

Explore how AI transforms cancer drug discovery by predicting proteins and accelerating drug candidate identification and ...

Research Institute today announced they have entered into an agreement with Janssen Research & Development, LLC, a Johnson & ...

By combining diverse datasets and powerful analytical and modeling tools, drug developers are finding more potential ...

At both Biotech Showcase and RESI JPM, BullFrog AI will highlight its proprietary BullFrog Data Networks ®, a data insights tool powered by the bfLEAP™ platform. BullFrog Data Networks ® evaluate high ...

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

MIT's open-source AI model, Boltz-1, could transform drug discovery by accurately predicting protein structures.

It is hard to overestimate the importance of antibodies in the frameworks of biotechnology and pharmaceutical industries.

Pfizer is expanding its collaboration with the start-up PostEra, which applies artificial intelligence to medicinal chemistry ...